Form 4 holding
Chief Financial Officer
Indaptus Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 26,758
- Estimated value
- $54,318
- Report date
- 22 Dec 2025
- Price
- $2.03
- Ownership
- Direct
Nir Sassi - Chief Financial Officer at Indaptus Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- INDP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Nir Sassi since 12 Jul 2025
Reported holdings for Nir Sassi in Indaptus Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
Indaptus Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 10 Apr 2025
- Price
- $0.0710
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Nir Sassi in Indaptus Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.